Cancer is a complex disease that evades the immune system through various mechanisms. The rapid proliferation of cells and their ability to resist therapy make cancer extremely aggressive. Solid ...

To make the therapy safer and more adaptable, UChicago researchers developed a new “split” system called GA1CAR. This uses ...

“Our study contributes to the development of a DNAm biomarker that integrates conventional BC risk factors to better reflect the risk for BC subtypes, promoting epigenetically targeted preventive ...

A new research paper was published in Oncotarget's Volume 15 on June 13, 2024, entitled, "Assessment of serum tumor markers CEA, CA-125, and CA19-9 as adjuncts in non-small cell lung cancer management ...

Researchers from the University of Sheffield, working in collaboration with Fiocruz-Bahia in Brazil, are shedding new light ...

This article explores how epigenetic mechanisms control gene expression, how their disruption drives cancer and how targeting ...

Existing oncology therapeutics are either so specific they can target only part of a tumor, or so generalized they kill healthy tissue.

Researchers at the Madrid Institute for Advanced Studies in Nanoscience (IMDEA Nanociencia) and the National Center for ...